Delivery Order SPE2DB20D3101-SPE2DB23FRAW9

Award Date 1/23/23
Potential Completion Date 1/24/23
Potential Value $4.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,071.60 Firm Fixed Price Delivery Order covers the supply of 4,566,339,514 units of the prescription drug Anastrozole 1 mg Tablets. The award has an ultimate completion date of November 6, 2024. Amerisourcebergen holds a separate $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, as...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $28,608.26 firm fixed-price delivery order is for the supply of 4560913012 - Anastrozole 1 mg tablet 90s, with a performance period ending on May 12, 2023. The contract is not set aside for any specific business type. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $1,791.12, is for the delivery of Anastrozole 1 mg Tablets in quantities of 90 per bottle. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,613.22 fixed-price delivery order is for the supply of 90-count packages of the drug Anastrozole 1 mg tablets. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,548.90, is for the delivery of 4560665798 Anastrozole 1 mg tablets in quantities of 90. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 21, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,157.20 contract is for the delivery of 4,560,051,951 units of Anastrozole 1 mg tablets. The contract has an ultimate completion date of February 27, 2023 and was awarded on February 24, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 90-count tablets of the medication Anastrozole 1 mg, with a ceiling value of $2,088.87 and a completion date of May 10, 2023. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, with a $1,897.37 ceiling value, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4560137029 - ANASTROZOLE 1 MG TABLET 30S. There is no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999,...
This firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,110.69 contract is for the supply of 30-count tablets of the drug Anastrozole 1 mg, a medication used to treat breast cancer. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,561,502,484 tablets of Anastrozole 1 mg. The contract has a ceiling value of $6,393.88 and a completion date of July 17, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FRAW9
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,454.04 firm-fixed-price delivery order is for the supply of 90-count bottles of the drug Anastrozole 1 mg tablets. The contract has an ultimate completion date of January 24, 2023 and was awarded on January 23, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is part of that larger IDC and does not have a set-aside designation, indicating open competition. In addition to the DLA contract, AmerisourceBergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 2/27/25, 11:24 AM